ArticlePloS one2020
Long-term treatment response after intravitreal bevacizumab injections for patients with central serous chorioretinopathy.
Hae Min Kang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it